Gi. Byrne et al., WORKSHOP ON IN-VITRO NEUTRALIZATION OF CHLAMYDIA-TRACHOMATIS - SUMMARY OF PROCEEDINGS, The Journal of infectious diseases, 168(2), 1993, pp. 415-420
A task force evaluated an in vitro antibody-mediated chlamydial neutra
lization assay for its utility as a method to assess functional correl
ates of antibody responses to Chlamydia trachomatis. Two monoclonal an
tibodies that recognize different major outer membrane protein (MOMP)
epitopes for a C. trachomatis serovar B strain exhibit good in vitro n
eutralizing activity, with a maximum of 90% neutralization. Calculatio
ns based on the 50% neutralization point indicated that 100% neutraliz
ation could theoretically be achieved when only 10% of the MOMP molecu
les bound antibody. Monoclonal antibodies that recognized either a het
erologous MOMP or the genus-specific chlamydial lipopolysaccharide did
not produce neutralizing activity. The standardized assay will be use
ful to establish if in vitro neutralizing antibody responses are predi
ctive of protective immunity and will aid in defining chlamydial antig
ens and epitopes that may be attractive vaccine candidates.